» Articles » PMID: 36902700

Increasing Number of Cases Due to in North Italy, July 2019-December 2022

Abstract

is an emerging fungus that represents a serious health threat globally. In Italy, the first case was detected in July 2019. Then, one case was reported to the Ministry of Health (MoH) on January 2020. Nine months later, a huge number of cases were reported in northern Italy. Overall, 361 cases were detected in 17 healthcare facilities between July 2019 and December 2022 in the Liguria, Piedmont, Emilia-Romagna, and Veneto regions, including 146 (40.4%) deaths. The majority of cases (91.8%) were considered as colonised. Only one had a history of travel abroad. Microbiological data on seven isolates showed that all but one strain (85.7%) were resistant to fluconazole. All the environmental samples tested negative. Weekly screening of contacts was performed by the healthcare facilities. Infection prevention and control (IPC) measures were applied locally. The MoH nominated a National Reference Laboratory to characterise isolates and store the strains. In 2021, Italy posted two messages through the Epidemic Intelligence Information System (EPIS) to inform on the cases. On February 2022, a rapid risk assessment indicated a high risk for further spread within Italy, but a low risk of spread to other countries.

Citing Articles

Antifungal stewardship in the UK: where are we now?.

Schelenz S, Agrawal S, Brady A, Kiely G, Riaz Z, Howes E JAC Antimicrob Resist. 2025; 7(1):dlae209.

PMID: 39741653 PMC: 11685713. DOI: 10.1093/jacamr/dlae209.


The Infection After the COVID-19 Pandemic Seems to be an Urgent Public Health Emergency: A Call to Attention.

Rahman M, Victoros E, Shanjana Y, Thomas M, Islam M Health Sci Rep. 2024; 7(11):e70160.

PMID: 39474347 PMC: 11519541. DOI: 10.1002/hsr2.70160.


First Case of Candida Auris Sepsis in Southern Italy: Antifungal Susceptibility and Genomic Characterisation of a Difficult-to-Treat Emerging Yeast.

Stolfa S, Caggiano G, Ronga L, Dalfino L, Centrone F, Sallustio A Microorganisms. 2024; 12(10).

PMID: 39458271 PMC: 11509443. DOI: 10.3390/microorganisms12101962.


Terbinafine Resistance in Strains Isolated from Humans and Animals: A Retrospective Cohort Study in Italy, 2016 to May 2024.

Crotti S, Cruciani D, Sabbatucci M, Spina S, Piscioneri V, Torricelli M J Clin Med. 2024; 13(18).

PMID: 39336980 PMC: 11432958. DOI: 10.3390/jcm13185493.


Fourier Transform Infrared Spectroscopy Application for Outbreak Typing in a Referral Intensive Care Unit: Phylogenetic Analysis and Clustering Cut-Off Definition.

Curtoni A, Pastrone L, Cordovana M, Bondi A, Piccinini G, Genco M Microorganisms. 2024; 12(7).

PMID: 39065082 PMC: 11279149. DOI: 10.3390/microorganisms12071312.


References
1.
Kohlenberg A, Struelens M, Monnet D, Plachouras D . epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017. Euro Surveill. 2018; 23(13). PMC: 5883451. DOI: 10.2807/1560-7917.ES.2018.23.13.18-00136. View

2.
Johnson E, Borman A . Susceptibility Testing of Candida auris Isolates. Methods Mol Biol. 2022; 2517:55-71. DOI: 10.1007/978-1-0716-2417-3_5. View

3.
Thoma R, Seneghini M, Seiffert S, Vuichard Gysin D, Scanferla G, Haller S . The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the.... Antimicrob Resist Infect Control. 2022; 11(1):12. PMC: 8777447. DOI: 10.1186/s13756-022-01052-8. View

4.
Rossi A, Chavez J, Iverson T, Hergert J, Oakeson K, Lacross N . Candida auris Discovery through Community Wastewater Surveillance during Healthcare Outbreak, Nevada, USA, 2022. Emerg Infect Dis. 2023; 29(2):422-425. PMC: 9881792. DOI: 10.3201/eid2902.221523. View

5.
Bandara H, Samaranayake L . Emerging strategies for environmental decontamination of the nosocomial fungal pathogen . J Med Microbiol. 2022; 71(6). DOI: 10.1099/jmm.0.001548. View